Related references
Note: Only part of the references are listed.Identification of new P-glycoprotein inhibitors derived from cardiotonic steroids
Maen Zeino et al.
BIOCHEMICAL PHARMACOLOGY (2015)
A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance
Shang-Hsun Tsou et al.
PLOS ONE (2015)
Chemical approaches to targeting drug resistance in cancer stem cells
Panagiota A. Sotiropoulou et al.
DRUG DISCOVERY TODAY (2014)
Cyclopamine: From Cyclops Lambs to Cancer Treatment
Stephen T. Lee et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2014)
Resveratrol Modulates the Topoisomerase Inhibitory Potential of Doxorubicin in Human Colon Carcinoma Cells
Anika Schroeter et al.
MOLECULES (2014)
Surface Markers of Cancer Stem Cells in Solid Tumors
Pu Xia
CURRENT STEM CELL RESEARCH & THERAPY (2014)
Cyclopamine analogs bearing exocyclic methylenes are highly potent and acid-stable inhibitors of hedgehog signaling
Johann Moschner et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2013)
Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm
Ferdinando Mannello
BMC MEDICINE (2013)
Structure of the human smoothened receptor bound to an antitumour agent
Chong Wang et al.
NATURE (2013)
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
Karthika Natarajan et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Bhuvaneswari Ramaswamy et al.
CANCER RESEARCH (2012)
Chemoresistance in Prostate Cancer Cells Is Regulated by miRNAs and Hedgehog Pathway
Saurabh Singh et al.
PLOS ONE (2012)
Chemosensitization of tumors by resveratrol
Subash C. Gupta et al.
RESVERATROL AND HEALTH (2011)
Cyclopamine modulates ABCG2 activity in glioblastoma side population cells
Jana Balbuena et al.
CANCER RESEARCH (2011)
Exo-Cyclopamine-a stable and potent inhibitor of hedgehog-signaling
Philipp Heretsch et al.
CHEMICAL COMMUNICATIONS (2011)
Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified
Steven Ray Wilson et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo)
Xiaomei Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Enhancement of Doxorubicin Cytotoxicity on Human Esophageal Squamous Cell Carcinoma Cells by Indomethacin and 4-[5-(4-Chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via Inhibiting P-Glycoprotein Activity
Le Yu et al.
MOLECULAR PHARMACOLOGY (2009)
Hedgehog Pathway Inhibitor HhAntag691 Is a Potent Inhibitor of ABCG2/BCRP and ABCB1/Pgp
Yimao Zhang et al.
NEOPLASIA (2009)
Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport
J. Sims-Mourtada et al.
ONCOGENE (2007)
Contrasting features of MDR phenotype in leukemias by using two fluorochromes: Implications for clinical practice
Flavia C. Vasconcelos et al.
LEUKEMIA RESEARCH (2007)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)
Share Paper
